The Significance of Inflammation in Atrial Fibrillation

Overview

Journal Curr Health Sci J

Specialty General Medicine

Date 2024 Jun 7

PMID 38846471

Authors

Ciprian Rachieru

Daniel-Florin Lighezan

Lucian Petrescu

Georgica Tartea

Emilia Violeta Goanta

Roxana Buzas

Liviu Cirin

Dragos Cozma

Affiliations

Soon will be listed here.

Abstract

Aim: The aim of the study was to assess the inflammatory status in individuals diagnosed with atrial fibrillation (Afi) and establish an association between this status and the clinicopathological features.

Material And Methods: Our study was conducted retrospectively and initially involved 278 patients. However, after excluding 27 patients, we ultimately ended up with 167 patients who had an inflammatory status and 84 patients who did not have an inflammatory status. These patients were then analyzed.

Results: Patients who had inflammation showed higher values for the CHA2DS2-VASc and HAS-BLED scores (P= 0.0132 for CHA2DS2-VASc and P= 0.0024 for HAS-BLED). Also, it was observed that patients with associated inflammation exhibited an increase in both the volume and the area of the left atrium. Patients with hypertension had a higher prevalence of inflammation, with heart failure and with ischemic heart disease. It is worth noting that patients with atrial fibrillation and increased inflammatory status exhibited higher rates of stroke (22.75% vs 10.71% in patients without inflammation, odds ratio = 2.455, 95% confidence interval 1.161 to 5.425, p = 0.0253).

Conclusions: Our research has demonstrated that patients diagnosed with atrial fibrillation and exhibiting a heightened inflammatory status also present association with other comorbidities, including hypertension, heart failure, ischemic heart disease, and stroke.

References

Hofmann U, Frantz S . How can we cure a heart "in flame"? A translational view on inflammation in heart failure. Basic Res Cardiol. 2013; 108(4):356. PMC: 3709073. DOI: 10.1007/s00395-013-0356-y. View

Aoki Y, Hatakeyama N, Yamamoto S, Kinoshita H, Matsuda N, Hattori Y . Role of ion channels in sepsis-induced atrial tachyarrhythmias in guinea pigs. Br J Pharmacol. 2011; 166(1):390-400. PMC: 3415663. DOI: 10.1111/j.1476-5381.2011.01769.x. View

Boos C, Anderson R, Lip G . Is atrial fibrillation an inflammatory disorder?. Eur Heart J. 2005; 27(2):136-49. DOI: 10.1093/eurheartj/ehi645. View

Morgera T, Di Lenarda A, Dreas L, Pinamonti B, Humar F, Bussani R . Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J. 1992; 124(2):455-67. DOI: 10.1016/0002-8703(92)90613-z. View

Lazzerini P, Capecchi P, Laghi-Pasini F . Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2016; 38(22):1717-1727. DOI: 10.1093/eurheartj/ehw208. View

Fang J, Kong B, Shuai W, Xiao Z, Dai C, Qin T . Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia. Eur J Pharmacol. 2021; 913:174622. DOI: 10.1016/j.ejphar.2021.174622. View

Ridker P, Bhatt D, Pradhan A, Glynn R, MacFadyen J, Nissen S . Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet. 2023; 401(10384):1293-1301. DOI: 10.1016/S0140-6736(23)00215-5. View

Maixent J, Paganelli F, Scaglione J, Levy S . Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 1998; 9(6):612-7. DOI: 10.1111/j.1540-8167.1998.tb00942.x. View

Koyfman L, Brotfain E, Kutz R, Frenkel A, Schwartz A, Boniel A . Epidemiology of new-onset paroxysmal atrial fibrillation in the General Intensive Care Unit population and after discharge from ICU. A retrospective epidemiological study. Anaesthesiol Intensive Ther. 2015; 47(4):309-14. DOI: 10.5603/AIT.a2015.0040. View

10.

Dobrev D, Heijman J, Hiram R, Li N, Nattel S . Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology. Nat Rev Cardiol. 2022; 20(3):145-167. PMC: 9477170. DOI: 10.1038/s41569-022-00759-w. View

11.

Wu N, Xu B, Xiang Y, Wu L, Zhang Y, Ma X . Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Int J Cardiol. 2013; 169(1):62-72. DOI: 10.1016/j.ijcard.2013.08.078. View

12.

Sun Z, Zhou D, Xie X, Wang S, Wang Z, Zhao W . Cross-talk between macrophages and atrial myocytes in atrial fibrillation. Basic Res Cardiol. 2016; 111(6):63. PMC: 5033992. DOI: 10.1007/s00395-016-0584-z. View

13.

Cheng C, Cheng C, Lee J, Lin H, Cheng C, Chien W . New-onset atrial fibrillation-related ischemic stroke occurring after hospital discharge in septicemia survivors. QJM. 2017; 110(7):453-457. DOI: 10.1093/qjmed/hcx025. View

14.

Andrade J, Khairy P, Dobrev D, Nattel S . The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014; 114(9):1453-68. DOI: 10.1161/CIRCRESAHA.114.303211. View

15.

Bruins P, Te Velthuis H, Yazdanbakhsh A, Jansen P, van Hardevelt F, de Beaumont E . Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997; 96(10):3542-8. DOI: 10.1161/01.cir.96.10.3542. View

16.

Libby P, Tabas I, Fredman G, Fisher E . Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res. 2014; 114(12):1867-79. PMC: 4078767. DOI: 10.1161/CIRCRESAHA.114.302699. View

17.

Heijman J, Guichard J, Dobrev D, Nattel S . Translational Challenges in Atrial Fibrillation. Circ Res. 2018; 122(5):752-773. DOI: 10.1161/CIRCRESAHA.117.311081. View

18.

Nattel S, Heijman J, Zhou L, Dobrev D . Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective. Circ Res. 2020; 127(1):51-72. PMC: 7398486. DOI: 10.1161/CIRCRESAHA.120.316363. View

19.

Walkey A, Greiner M, Heckbert S, Jensen P, Piccini J, Sinner M . Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors. Am Heart J. 2013; 165(6):949-955.e3. PMC: 3695631. DOI: 10.1016/j.ahj.2013.03.020. View

20.

Nattel S, Burstein B, Dobrev D . Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2009; 1(1):62-73. DOI: 10.1161/CIRCEP.107.754564. View